Tilray Brands receives trading license in Germany, allowing Aphria RX GmbH to sell medical marijuana products.
Tilray Brands, a Canadian cannabis company, has received a trading license in Germany, allowing its subsidiary Aphria RX GmbH to sell and distribute medical marijuana products to pharmacies, hospitals, and medical wholesalers. This comes after Aphria RX obtained the first new cannabis cultivation license under Germany's new Cannabis Act. The licenses expand Tilray's leadership in medical cannabis research, cultivation, production, and distribution in Germany.
July 29, 2024
5 Articles